Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1585–1608 of 8,271 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Fetal Development
Interventions: Not listed
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Memphis, Tennessee

Conditions: Macular Degeneration
Interventions: Rheopheresis blood filtration; Device
Lead sponsor: OccuLogix; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2005
U.S. locations: 7
States / cities: Beverly Hills, California • Coral Gables, Florida • Fort Myers, Florida + 4 more

Conditions: Nephrolithiasis
Interventions: Ultrasound-first Clinical Decision Support tool; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 75 Years
Enrollment: 388 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Alcohol Consumption, Fetal Alcohol Syndrome Disorders, Students
Interventions: Self-guided Motivational Intervention, Informational Only; Behavioral
Lead sponsor: Nova Southeastern University; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 354 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Fort Lauderdale, Florida

Conditions: MELAS Syndrome
Interventions: Fluzone®; Biological
Lead sponsor: Stanford University; Other
Eligibility: 13 Years to 65 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Mindful Movement Intervention (MMI)
Interventions: Mindful Movement Intervention; Behavioral
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 7 Years to 15 Years
Enrollment: 196 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Thrombocytopenia, Neonatal Alloimmune
Interventions: Nipocalimab, Intravenous immunoglobulins (IVIG), Prednisone; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 16
States / cities: Birmingham, Alabama • Sacramento, California • Aurora, Colorado + 13 more

Conditions: Pregnancy
Interventions: Diagnostic Ultrasound System; Device
Lead sponsor: United Imaging Healthcare North America, Inc.; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Keratoconus
Interventions: Artemis Ultrasound Exam, Optical Coherence Tomography (OCT) Exam; Procedure
Lead sponsor: Columbia University; Other
Eligibility: 6 Years to 65 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Prostate Cancer
Interventions: Observation; Other
Lead sponsor: BioProtect; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Lake Success, New York

Conditions: Cerebral Palsy Children, Healthy Adults
Interventions: Neuromuscular Electrical Stimulation (NMES); Device
Lead sponsor: University of Nebraska; Other
Eligibility: 7 Years to 40 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Diabetes
Interventions: Low Dose Sinemet CR, High Dose Sinemet CR, RETeval Electroretinogram (ERG) Testing, Contrast Sensitivity Testing, Visual Acuity Testing; Drug · Device · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: E.Coli Infections
Interventions: Not listed
Lead sponsor: MJM Bonten; Other
Eligibility: 60 Years and older
Enrollment: 4,479 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Long Acting Reversible Contraception, Contraception Behavior
Interventions: Telehealth-supported LARC provision; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 13 Years to 22 Years · Female only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Reproductive Aging
Interventions: Women undergoing IVF/ART cycles at OU Physicians Reproductive Health Clinic in Oklahoma City, Oklahoma; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Psoriasis, Atopic Dermatitis
Interventions: Blood pressure, Height, Weight, BMI, Waist Circumference; Other
Lead sponsor: Northwestern University; Other
Eligibility: 5 Years to 17 Years
Enrollment: 409 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 9
States / cities: San Diego, California • San Francisco, California • Stanford, California + 6 more

Conditions: Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease, Obesity
Interventions: Not listed
Lead sponsor: Texas A&M University; Other
Eligibility: 30 Years and older
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: College Station, Texas

Conditions: Postoperative Pain Management
Interventions: Exparel, 0.5% Bupivacaine HCl; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 17
States / cities: Loma Linda, California • Sacramento, California • Stanford, California + 14 more

Conditions: Pneumococcal Immunization
Interventions: PCV21 vaccine, Prevnar 20 vaccine, M-M-R II vaccine, Rotarix, RotaTeq, Vaxelis vaccine, Varivax, Priorix, VAQTA, Havrix; Biological
Lead sponsor: Sanofi; Industry
Eligibility: 42 Days to 89 Days
Enrollment: 580 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 17
States / cities: Los Angeles, California • Hollywood, Florida • Miami, Florida + 13 more

Conditions: Pneumococcal Vaccines
Interventions: 31-valent pneumococcal conjugate vaccine, PCV20; Biological
Lead sponsor: Vaxcyte, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 752 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 30
States / cities: Chinle, Arizona • Phoenix, Arizona • Whiteriver, Arizona + 27 more

Conditions: Traumatic Brain Injury, Hypopituitarism
Interventions: Blast Traumatic Brain Injury; Other
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Seizures, Epilepsies, Partial, Epilepsy, Complex Partial, Epilepsy, Generalized, Epilepsy
Interventions: Placebo, Vanquix Auto-Injector (Diazepam Injection); Drug
Lead sponsor: Pfizer; Industry
Eligibility: 2 Years and older
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 86
States / cities: Northport, Alabama • Little Rock, Arkansas • Irvine, California + 44 more

Conditions: Multiple Sclerosis, Relapsing-Remitting
Interventions: dimethyl fumarate; Drug
Lead sponsor: Biogen; Industry
Eligibility: 10 Years to 17 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: San Bernardino, California

Conditions: Venous Thromboembolism
Interventions: Rivaroxaban (Xarelto, BAY59-7939); Drug
Lead sponsor: Bayer; Industry
Eligibility: 6 Months to 5 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 5
States / cities: Gainesville, Florida • Pensacola, Florida • Atlanta, Georgia + 2 more

Search by objective public record fields.

Biophysical Profile in Preterm Pregnancies

Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)

Ultrasound First Clinical Decision Support for Suspected Nephrolithiasis

A Media Based Motivational Intervention to Prevent Alcohol Exposed Pregnancies (AEPs)

Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)

Examining Effects of Holistic School Enrichment Programs

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Technology Development of Diagnostic Ultrasound System for Obstetric Imaging

Keratoconus Detection by Ultrasound

Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)

Evaluating the Effects of an Electrical Stimulator on Improving the Walking Ability of Children With Cerebral Palsy

The Effect of Dopamine on Diabetic Retinopathy

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1)

Study of the Implementation of Telehealth-Supported LARC Provision in School-Based Health Centers

Assisted Reproductive Technology (ART) Predictors Study

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

Fat Metabolism in OSA and COPD

Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination

Hormone Deficiency After Brain Injury During Combat

Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.

Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS

EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis